Leadership-BGI Group Official Website

Mu Feng

CEO of MGI

Mu Feng, CEO of MGI, and his team are committed to breaking down barriers in the area of science and technology, and building MGI into a global leader in providing industry core tools and conducting life science research. He actively promotes the research and development of cutting-edge genomics research and medical equipment. He has participated in or advocated multiple projects including the completion of the 1% genome sequencing project of the International Human Genome Project, the Rice Genome Project, the National “Ninth Five-Year Plan” project HIV testing reagents, the SARS research of the Ministry of Science and Technology, and the national major project “Precision Medical Research”. He has led the development and application of multi-disciplinary and multi-platform products in areas such as reproductive health, infectious diseases and tumor disease detection, and published nearly 100 papers, and obtained nearly 100 registration certificates and patents. He has been especially invited to the "Innovative and Sustainable Development" high-level forum held at the United Nations Headquarters in New York, the sixth China-Central and Eastern European country leaders "16+1" signing ceremony, and gave speeches on behalf of BGI as the leader in the global genetics industry.
Since joining BGI in 1998, he has held core leadership positions in research, intellectual development, industry, and regional fields. He served as the rotating CEO of the BGI Group in 2017. Mu Feng is a Natural Science Researcher and he graduated from the Graduate School of the Chinese Academy of Sciences with a Ph.D. in Genetics.

Curiosity, Application of Knowledge, Working for the Betterment of Mankind.

Mu Feng

Curiosity, Application of Knowledge,
Working for the Betterment of Mankind.